AMPH — Amphastar Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.12bn
- $1.45bn
- $719.89m
U.S. RESEARCH ROUNDUP-Bluebird Bio, Smiledirectclub, Whitehorse Finance
Amphastar Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Amphastar Pharmaceuticals Says Co & Two Domestic Subsidiaries Entered Into $140 Mln Senior Secured Credit Facility
Amphastar Pharmaceuticals Inc expected to post earnings of 21 cents a share - Earnings Preview
Brief: Amphastar Announces Buyback Of 26% Of The Equity In Its Anp Subsidiary And Spin-Off Its Hanxin Subsidiary
Amphastar Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Amphastar Pharmaceuticals Q1 Adjusted Non-GAAP Earnings Per Share $0.27
Amphastar Pharmaceuticals Inc expected to post earnings of 18 cents a share - Earnings Preview
Brief: Amphastar Pharmaceuticals Receives FDA Approval For Morphine Sulfate Injection
Brief: Amphastar Pharmaceuticals Receives FDA Approval For Dextrose Injection
U.S. RESEARCH ROUNDUP- East West Bancorp, Genmark Diagnostics, iHeartMedia
Brief: Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Full-Year Ended December 31, 2020
U.S. STOCKS ON THE MOVE-Amphastar Pharma, Snap, Aprea Therapeutics
U.S. STOCKS ON THE MOVE-Disney, Moleculin, Applied DNA
Amphastar Pharma: Jumps on FDA nod for generic version of hypoglycemia drug
Brief: Amphastar Announces Approval For Glucagon For Injection Kit, 1Mg
Brief: FDA Approves First Generic Of Drug Used To Treat Severe Hypoglycemia
Brief: Amphastar Pharmaceuticals Reports Q3 EPS Of $0.08
U.S. STOCKS ON THE MOVE-Facebook, Amazon.com, Nvidia